Non-Invasive Determination of Fetal Chromosome Abnormalities

Sponsor
Lenetix Medical Screening Laboratory (Industry)
Overall Status
Unknown status
CT.gov ID
NCT00891852
Collaborator
(none)
1,000
7
11
142.9
13

Study Details

Study Description

Brief Summary

The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Non-Invasive Determination of Fetal Chromosome Abnormalities
Study Start Date :
Jan 1, 2009
Anticipated Primary Completion Date :
Dec 1, 2009
Anticipated Study Completion Date :
Dec 1, 2009

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • This study is only applicable to women who are between 8 and 30 weeks' gestation and who have been determined increased risk for fetal aneuploidy. In the interest of expediting and simplifying this study, the investigators want only women who have already decided to undergo second-trimester amniocentesis or CVS.
    Exclusion Criteria:
    • The only exclusion criteria are those mentioned.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maryland Perinatal Associates Rockville Maryland United States 20850
    2 Atlantic Maternal Fetal Medicine Moristown New Jersey United States 07960
    3 Winthrop University Hospital Mineola New York United States 11501
    4 Elite Women's Health New Hyde Park New York United States 11042
    5 Columbia University, NewYork-Presbyterian Hospital New York New York United States 10022
    6 New York Perinatal Associates New York New York United States 10128
    7 UVM Burlington Vermont United States 05405

    Sponsors and Collaborators

    • Lenetix Medical Screening Laboratory

    Investigators

    • Principal Investigator: Stephen A Brown, MD, Lenetix, Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00891852
    Other Study ID Numbers:
    • 110106-1
    First Posted:
    May 1, 2009
    Last Update Posted:
    May 1, 2009
    Last Verified:
    Apr 1, 2009

    Study Results

    No Results Posted as of May 1, 2009